Potassium channel openers (KCOs) are important tools that are often used to
gain a greater understanding of K+ channels. Agents that can induce or mai
ntain the opening of K+ channels also offer a therapeutic approach to contr
olling of cell excitability and offer a means of producing stability in bio
logical systems. The pathogenesis of a broad range of peripheral disorders
(e.g., LQT syndrome, hypokalemic periodic paralysis, hyperinsulinism in inf
ancy and erectile dysfunction) are associated with dysfunctional K+ channel
s due to mutations in genes encoding channel proteins. The therapeutic pote
ntial of KCOs in peripheral K+ channelopathies is discussed. The identifica
tion of K+ channel subtype-specific openers offers discrete modulation of c
ellular systems creating a realistic therapeutic advance in the treatment o
f K+ channelopathies.